Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Current Leases (2019 - 2026)

Phibro Animal Health has reported Current Leases over the past 7 years, most recently at $9.0 million for Q4 2025.

  • For Q4 2025, Current Leases rose 11.72% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $9.0 million, up 11.72%, while the annual FY2025 figure was $9.1 million, 22.35% up from the prior year.
  • Current Leases for Q4 2025 was $9.0 million at Phibro Animal Health, down from $9.0 million in the prior quarter.
  • Over five years, Current Leases peaked at $9.1 million in Q2 2025 and troughed at $5.7 million in Q3 2022.
  • A 5-year average of $7.1 million and a median of $6.6 million in 2021 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: dropped 12.92% in 2022 and later grew 26.47% in 2025.
  • Year by year, Current Leases stood at $6.6 million in 2021, then dropped by 12.92% to $5.7 million in 2022, then increased by 21.83% to $7.0 million in 2023, then increased by 14.51% to $8.0 million in 2024, then grew by 11.72% to $9.0 million in 2025.
  • Business Quant data shows Current Leases for PAHC at $9.0 million in Q4 2025, $9.0 million in Q3 2025, and $9.1 million in Q2 2025.